Unique ID issued by UMIN | UMIN000050727 |
---|---|
Receipt number | R000057794 |
Scientific Title | Exploratory study on effects of Tochu (Eucommia ulmoides) leaf extract components on vascular and inflammatory indices in chronic kidney disease. |
Date of disclosure of the study information | 2023/03/30 |
Last modified on | 2024/09/29 09:33:21 |
Exploratory study on effects of Tochu (Eucommia ulmoides) leaf extract components on vascular and inflammatory indices in chronic kidney disease.
Exploratory study on effects of Tochu (Eucommia ulmoides) leaf extract components on vascular and inflammatory indices in chronic kidney disease.
Exploratory study on effects of Tochu (Eucommia ulmoides) leaf extract components on vascular and inflammatory indices in chronic kidney disease.
Exploratory study on effects of Tochu (Eucommia ulmoides) leaf extract components on vascular and inflammatory indices in chronic kidney disease.
Japan |
chronic kidney disease
Nephrology |
Others
NO
To explore effects of oral supplement (product name: Tochu gen Gx) containing Tochu tea extracts, taken at recommended dose for 10 (8-12) weeks, on vascular and inflammatory indices in chronic kidney disease (CKD) patients.
Safety,Efficacy
Circulating endothelial progenitor cell numbers by flowcytometry at the start and at the end of Tochu tea supplement administration for 10 (8-12) weeks.
Circulating monocyte subset ratios (flowcytometry) , serum adiponectin, high-sensetivity CRP, oxidized LDL, oxidative stress (ROM) and anti-oxidative (BAP) indices, at the start and at the end of Tochu tea supplement administration for 10 (8-12) weeks.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Food |
Tochu tea supplement (product name: Tochu gen GX) at recommended dose of 9 tablets per day is administered for 10 (8-12) weeks. Blood samples at the start and at the end of administration are used for outcome measurements including those by flowcytometry.
20 | years-old | <= |
Not applicable |
Male and Female
1. Chronic kidney disease patients at stages G1 to G3a (eGFR >45 mL/min/1.73m2) and/or proteinuria of more than 0.15g/gCr (or albuminuria of more than 30mg/gCr).
2. Males and females 20 years or more of age.
3. Those from whom consent to study participation was obtained with use of informed conset document.
1. Those with malignant disease.
2. Those with dementia or impaired cognitive function.
3. Those with serious comorbid conditions who were judged not suited for participation by physician.
50
1st name | Hiroshi |
Middle name | |
Last name | Satonaka |
Dokkyo Medical University
Department of Nephrology and Hypertension
321-0293
880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi-ken, JAPAN
0282-86-1111
satonakah@nifty.com
1st name | Hiroshi |
Middle name | |
Last name | Satonaka |
Dokkyo Medical University
Department of Nephrology and Hypertension
321-0293
880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi-ken, JAPAN
0282-86-1111
satonakah@nifty.com
Dokkyo Medical University
Japanaese Society of Eucommia
Other
Clinical Research Review Committee, Dokkyo Medical University Hospital
880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi-ken, JAPAN
+81-282-86-1111
r-kenkyu@dokkyomed.ac.jp
NO
2023 | Year | 03 | Month | 30 | Day |
Unpublished
Enrolling by invitation
2021 | Year | 08 | Month | 19 | Day |
2021 | Year | 09 | Month | 21 | Day |
2023 | Year | 03 | Month | 31 | Day |
2024 | Year | 08 | Month | 31 | Day |
2023 | Year | 03 | Month | 30 | Day |
2024 | Year | 09 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057794